Statin use not linked to COVID-19 mortality in hospitalized patients
Nov 09, 2021
Statin use was associated with an increased relative risk for severe disease among hospitalized patients with COVID-19.
mRNA COVID-19 vaccine less protective in elderly with comorbidity
Dec 23, 2021
At ≥7 days after the second dose, the effectiveness of mRNA COVID-19 vaccine was 69% against infection and 86% against related death.
Most with reaction to mRNA COVID-19 vaccine tolerate second dose
Jul 29, 2021
Most patients with an immediate, potentially allergic reaction to Pfizer-BioNTech or Moderna mRNA COVID-19 vaccine tolerate a second dose
Blacks, Latinx skeptical about COVID-19 vaccine, study says
By
Diane Eastabrook
Jul 16, 2021
Black and Latinx people have been more proactive than other races about seeking information about COVID-19, wearing masks and getting tested for the virus
COVID-19 vaccine hesitancy up for racial, ethnic minority healthcare workers
Aug 30, 2021
Vaccine hesitancy was highest among Black and Hispanic or Latino healthcare workers; concerns include side effects and the newness of the vaccine.
Electronic nudge for flu vaccination does not improve clinical outcomes
Mar 19, 2024
No significant difference was seen in hospitalization for pneumonia or influenza or in hospitalization for any cause or mortality.
Updated immunization schedule presented for adults for 2024
Jan 11, 2024
The changes include a recommendation for all adults to receive a dose of the new COVID-19 vaccine and RSV vaccination.
Veterans report low rates of adverse events with mRNA vaccines
Jun 16, 2022
Rates were slightly higher at 42 days for those receiving the Pfizer versus Moderna vaccine.
Recommended 2023 adult immunization schedule published
Feb 10, 2023
Changes include a new section relating to COVID-19 vaccines and the addition of a newly licensed vaccine for hepatitis B.
Risk for shoulder conditions small after vaccination in deltoid muscle
Mar 21, 2022
The incidence of shoulder conditions per 10,000 vaccinations was 1.22 for adults (age 18 years or older) and 0.05 for children (age 3 to 17 years).